Exelixis | 销售成本



Cost Of Sales 更改 日
Acadia Pharmaceuticals USD 20.39M 1.41M 2025-03
Agios Pharmaceuticals USD 1.08M 175K 2025-03
Amgen USD 2.6B 507M 2025-03
AstraZeneca USD 2.24B 484M 2025-03
Bayer EUR 5.62B 98M 2025-03
BioMarin Pharmaceutical USD 151.56M 15.42M 2025-03
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Cytokinetics 463K 79.14M 2024-09
Eisai JPY 40.6B 5.33B 2025-03
Eli Lilly USD 2.22B 179.6M 2025-03
Exelixis USD 19.17M 793K 2025-04
Genmab DKK 42M 295M 2025-03
Glaxosmithkline GBP 2.52B 199M 2024-12
Incyte USD 67.8M 14.58M 2025-03
Ionis Pharmaceuticals USD 1000K 2.83M 2025-03
MacroGenics USD 5.49M 3.62M 2024-12
Merck USD 2.76B 944M 2025-03
Moderna USD 90M 456M 2025-03
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Novartis USD 3.32B 90M 2024-12
Pfizer USD 2.59B 3.06B 2025-03
Sanofi EUR 2.27B 1.81B 2024-12
Takeda JPY 382.08B 34.8B 2025-03
Ultragenyx Pharmaceutical USD 28.66M 11.77M 2025-03
Xencor 10.71M 4.56M 2024-09



Exelixis 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2025.